ANI Pharmaceuticals, Inc. (ANIP)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 1.36B |
| Enterprise Value | 1.43B |
| Trailing P/E | 40.31 |
| Forward P/E | 15.31 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.37 |
| Price/Book (mrq) | 3.01 |
| Enterprise Value/Revenue | 2.77 |
| Enterprise Value/EBITDA | 11.31 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.81 |
| 52-Week Change 3 | 34.09% |
| S&P500 52-Week Change 3 | 23.49% |
| 52 Week High 3 | 70.81 |
| 52 Week Low 3 | 47.44 |
| 50-Day Moving Average 3 | 65.93 |
| 200-Day Moving Average 3 | 60.01 |
Share Statistics
| Avg Vol (3 month) 3 | 150.24k |
| Avg Vol (10 day) 3 | 124.97k |
| Shares Outstanding 5 | 20.96M |
| Implied Shares Outstanding 6 | 20.96M |
| Float 8 | 15.66M |
| % Held by Insiders 1 | 11.24% |
| % Held by Institutions 1 | 77.89% |
| Shares Short (May 15, 2024) 4 | 204.37k |
| Short Ratio (May 15, 2024) 4 | 1.54 |
| Short % of Float (May 15, 2024) 4 | 1.26% |
| Short % of Shares Outstanding (May 15, 2024) 4 | 0.98% |
| Shares Short (prior month Apr 15, 2024) 4 | 213.52k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:6 |
| Last Split Date 3 | Jul 18, 2013 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 6.87% |
| Operating Margin (ttm) | 10.95% |
Management Effectiveness
| Return on Assets (ttm) | 3.91% |
| Return on Equity (ttm) | 8.71% |
Income Statement
| Revenue (ttm) | 517.46M |
| Revenue Per Share (ttm) | 27.70 |
| Quarterly Revenue Growth (yoy) | 28.70% |
| Gross Profit (ttm) | N/A |
| EBITDA | 112.38M |
| Net Income Avi to Common (ttm) | 30.55M |
| Diluted EPS (ttm) | 1.61 |
| Quarterly Earnings Growth (yoy) | 1,165.30% |
Balance Sheet
| Total Cash (mrq) | 238.25M |
| Total Cash Per Share (mrq) | 12.28 |
| Total Debt (mrq) | 290.51M |
| Total Debt/Equity (mrq) | 60.93% |
| Current Ratio (mrq) | 3.95 |
| Book Value Per Share (mrq) | 23.26 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 115.8M |
| Levered Free Cash Flow (ttm) | 79.33M |
© 2024 Yahoo. All rights reserved.